Inhibition of RANKL- induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium- particle- induced osteolysis

Samankaltaisia teoksia

• The Inhibition of RANKL-Induced Osteoclastogenesis through the Suppression of p38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis
  Tekijä: Wang, Wengang, et al.
  Julkaistu: (2014)
• Puerarin inhibits titanium particle‐induced osteolysis and RANKL‐induced osteoclastogenesis via suppression of the NF‐κB signaling pathway
  Tekijä: Tang, Wenkai, et al.
  Julkaistu: (2020)
• Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo
  Tekijä: Chen, Shuai, et al.
  Julkaistu: (2015)
• Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
  Tekijä: Xu, Qiang, et al.
  Julkaistu: (2021)
• Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced Osteolysis
  Tekijä: Hui Li, et al.
  Julkaistu: (2018-11-01)